Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Russell

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
Clinical Drug Investigation|September 26, 2015
Exploratory study of total and free prednisolone plasma exposure and cushingoid appearance, quality of life and biochemical toxicity in adult male kidney transplant recipientsTroels K Bergmann, Nicole M Isbel, Remo Ostini, et al.
Eye & Contact Lens|August 21, 2010
Repeatability of measuring corneal subbasal nerve fiber length in individuals with type 2 diabetesNathan Efron, Katie Edwards, Nicola Roper, et al.
Bjpsych Open|April 27, 2026
SMART: preliminary efficacy, feasibility and acceptability of a theory-informed digital intervention for metabolic health in people with schizophrenia and related disordersUrska Arnautovska, Gabrielle Ritchie, Nicole Korman, et al.
Digestive Diseases (Basel, Switzerland)|November 3, 2022
Serum CC-Chemokine Ligand 2 Is Associated with Visceral Adiposity but Not Fibrosis in Patients with Non-Alcoholic Fatty Liver DiseaseMichelle Ferrari-Cestari, Satomi Okano, Preya J Patel, et al.
Diabetes, Obesity & Metabolism|December 29, 2025
Comparative effectiveness of glucose monitoring methods and glycaemic control in patients with type 2 diabetes: An umbrella reviewNathaniel Foo, Sri Chodapaneedi, Brayden Gibson, et al.
Annals of Hepatology|July 19, 2023
Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonistsLucy Gracen, Withma Muthukumara, Melanie Aikebuse, et al.
The Lancet. Psychiatry|June 12, 2025
Efficacy and safety of semaglutide versus placebo for people with schizophrenia on clozapine with obesity (COaST): a phase 2, multi-centre, participant and investigator- blinded, randomised controlled trial in AustraliaDan Siskind, Andrea Baker, Urska Arnautovska, et al.
Annals of the Rheumatic Diseases|February 4, 2012
Abatacept in subjects who switch from intravenous to subcutaneous therapy: results from the phase IIIb ATTUNE studyEdward Clark Keystone, Joel M Kremer, Anthony Russell, et al.
Pilot and Feasibility Studies|September 24, 2020
An app-, web- and social support-based weight loss intervention for adults with obesity: the 'HelpMeDoIt!' feasibility randomised controlled trialSharon Anne Simpson, Lynsay Matthews, Juliana Pugmire, et al.
BMC Public Health|August 4, 2010
Living Well with Diabetes: a randomized controlled trial of a telephone-delivered intervention for maintenance of weight loss, physical activity and glycaemic control in adults with type 2 diabetesElizabeth G Eakin, Marina M Reeves, Alison L Marshall, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Clinical Drug Investigation|September 26, 2015
Exploratory study of total and free prednisolone plasma exposure and cushingoid appearance, quality of life and biochemical toxicity in adult male kidney transplant recipientsTroels K Bergmann, Nicole M Isbel, Remo Ostini, et al.
Eye & Contact Lens|August 21, 2010
Repeatability of measuring corneal subbasal nerve fiber length in individuals with type 2 diabetesNathan Efron, Katie Edwards, Nicola Roper, et al.
Bjpsych Open|April 27, 2026
SMART: preliminary efficacy, feasibility and acceptability of a theory-informed digital intervention for metabolic health in people with schizophrenia and related disordersUrska Arnautovska, Gabrielle Ritchie, Nicole Korman, et al.
Digestive Diseases (Basel, Switzerland)|November 3, 2022
Serum CC-Chemokine Ligand 2 Is Associated with Visceral Adiposity but Not Fibrosis in Patients with Non-Alcoholic Fatty Liver DiseaseMichelle Ferrari-Cestari, Satomi Okano, Preya J Patel, et al.
Diabetes, Obesity & Metabolism|December 29, 2025
Comparative effectiveness of glucose monitoring methods and glycaemic control in patients with type 2 diabetes: An umbrella reviewNathaniel Foo, Sri Chodapaneedi, Brayden Gibson, et al.
Annals of Hepatology|July 19, 2023
Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonistsLucy Gracen, Withma Muthukumara, Melanie Aikebuse, et al.
The Lancet. Psychiatry|June 12, 2025
Efficacy and safety of semaglutide versus placebo for people with schizophrenia on clozapine with obesity (COaST): a phase 2, multi-centre, participant and investigator- blinded, randomised controlled trial in AustraliaDan Siskind, Andrea Baker, Urska Arnautovska, et al.
Annals of the Rheumatic Diseases|February 4, 2012
Abatacept in subjects who switch from intravenous to subcutaneous therapy: results from the phase IIIb ATTUNE studyEdward Clark Keystone, Joel M Kremer, Anthony Russell, et al.
Pilot and Feasibility Studies|September 24, 2020
An app-, web- and social support-based weight loss intervention for adults with obesity: the 'HelpMeDoIt!' feasibility randomised controlled trialSharon Anne Simpson, Lynsay Matthews, Juliana Pugmire, et al.
BMC Public Health|August 4, 2010
Living Well with Diabetes: a randomized controlled trial of a telephone-delivered intervention for maintenance of weight loss, physical activity and glycaemic control in adults with type 2 diabetesElizabeth G Eakin, Marina M Reeves, Alison L Marshall, et al.
Pageof 9